Represent the number of patents which are allegedly invalid.

No definition available.

Name:	lci_ContingencyEntitysPatentsValid
Namespace Prefix:	lci_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the number of drugs.

+ References

No definition available.

+ Details

Name:	lci_NumberOfDrugs
Namespace Prefix:	lci_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of Government entity customers for whom the entity completed contract compliance review.

+ References

No definition available.

+ Details

Name:	lci_NumberOfGovernmentEntityCustomersForWhomEntityCompletedContractComplianceReview
Namespace Prefix:	lci_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the number of officers.

+ References

No definition available.

+ Details

Name:	lci_NumberOfOfficers
Namespace Prefix:	lci_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the number of opt-out purchasers who filed a complaint alleging conspiracy against Company and numerous other defendants.

+ References

No definition available.

+ Details

Name:	lci_NumberOfOptOutPurchasers
Namespace Prefix:	lci_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the number of states.

+ References

No definition available.

+ Details

Name:	lci_NumberOfStates
Namespace Prefix:	lci_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Cash inflow for litigation settlement from prior holding company.

+ References

No definition available.

+ Details

Name:	lci_ProceedsForLitigationSettlement
Namespace Prefix:	lci_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.10)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name:	us-gaap_EscrowDeposit
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount awarded to other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.

+ References

+ Details

Name:	us-gaap_LossContingencyAccrualCarryingValueNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of damages paid to the plaintiff in the legal matter.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349

+ Details

Name:	us-gaap_LossContingencyDamagesPaidValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349

+ Details

Name:	us-gaap_LossContingencyEstimateOfPossibleLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The total number of new claims filed pertaining to a loss contingency during the period.

+ References

+ Details

Name:	us-gaap_LossContingencyNewClaimsFiledNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of defendants named in a legal action.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingencyNumberOfDefendants
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_ProductOrServiceAxis=lci_ZomigMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=lci_ConnecticutAttorneyGeneralInquiryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ProductOrServiceAxis=lci_DoxycyclineMonohydrateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=lci_TexasMedicaidInvestigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=lci_GovernmentPricingMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=lci_EpaViolationNoticeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=lci_PrivateAntitrustAndConsumerProtectionLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationCaseAxis=lci_ShareholderLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Legal, Regulatory Matters and Contingencies (Details)			1 Months Ended					3 Months Ended	6 Months Ended
Legal, Regulatory Matters and Contingencies (Details)	Jan. 22, 2018 item product	Jul. 13, 2017 USD ($)	Dec. 31, 2018 USD ($) product	Oct. 31, 2018 item	Nov. 30, 2016 item	Sep. 30, 2014 lawsuit	Jul. 31, 2014 lawsuit patent	Dec. 31, 2016 customer	Dec. 31, 2018 USD ($) Distributor lawsuit product patent	Jan. 16, 2019 product	Aug. 03, 2018 product	Jun. 30, 2018 USD ($)	Jun. 18, 2018 product	Jun. 07, 2018 product	Oct. 31, 2017 state product	Oct. 06, 2017 product	Nov. 24, 2015 USD ($)
Zomig
Legal, Regulatory Matters and Contingencies
Number of lawsuits \| lawsuit						1	2
Patents allegedly invalid \| patent									2
Patents allegedly infringed \| patent							2
Connecticut Attorney General Inquiry
Legal, Regulatory Matters and Contingencies
Number of drugs \| product															13
Connecticut Attorney General Inquiry \| Doxycycline Monohydrate
Legal, Regulatory Matters and Contingencies
Number of drugs \| product															1
Texas Medicaid Investigation
Legal, Regulatory Matters and Contingencies
Litigation settlement amount payable to other party			$ 8,000,000
Proceeds from UCB for litigation settlement			8,000,000
Government Pricing
Legal, Regulatory Matters and Contingencies
Compliance reviews, number of customers \| customer								1
Liability estimate			$ 9,300,000						$ 9,300,000			$ 9,300,000
FDIC Indemnification Asset																	$ 8,300,000
EPA Violation Notice
Legal, Regulatory Matters and Contingencies
Payment to litigation settlement		$ 60,000
Escrow deposit		$ 225,000
Private Antitrust and Consumer Protection Litigation
Legal, Regulatory Matters and Contingencies
Number of drugs \| product			18						18	30	16		15	14		6
Number of manufacturers and distributors \| Distributor									30
Number of States \| state															48
Opt-out purchasers, number \| item	3
Private Antitrust and Consumer Protection Litigation \| Minimum
Legal, Regulatory Matters and Contingencies
Number of drugs \| product	30
Number of lawsuits \| lawsuit									100
Shareholder Litigation
Legal, Regulatory Matters and Contingencies
Number of officers \| item				2	2